These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
245 related items for PubMed ID: 25102738
41. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study. Xenellis J, Papadimitriou N, Nikolopoulos T, Maragoudakis P, Segas J, Tzagaroulakis A, Ferekidis E. Otolaryngol Head Neck Surg; 2006 Jun; 134(6):940-5. PubMed ID: 16730534 [Abstract] [Full Text] [Related]
42. Simultaneous versus subsequent intratympanic dexamethasone for idiopathic sudden sensorineural hearing loss. Park MK, Lee CK, Park KH, Lee JD, Lee CG, Lee BD. Otolaryngol Head Neck Surg; 2011 Dec; 145(6):1016-21. PubMed ID: 21817157 [Abstract] [Full Text] [Related]
43. Potential Benefits of Combination Therapy as Primary Treatment for Sudden Sensorineural Hearing Loss. Lee JB, Choi SJ. Otolaryngol Head Neck Surg; 2016 Feb; 154(2):328-34. PubMed ID: 26556463 [Abstract] [Full Text] [Related]
44. Probability of clinically significant hearing recovery following salvage intratympanic steroids for sudden sensorineural hearing loss in the 'real world'. Li LQ, Bennett AMD. J Laryngol Otol; 2022 Sep; 136(9):831-838. PubMed ID: 35581906 [Abstract] [Full Text] [Related]
45. Intratympanic steroid injection as a first-line therapy in uremia patients with sudden sensorineural hearing loss. Tsai HT, Hsueh N, Huang CM, Lin HC. Acta Otolaryngol; 2015 Aug; 135(8):786-90. PubMed ID: 25783847 [Abstract] [Full Text] [Related]
46. Intratympanic methylprednisolone administration promotes the recovery of idiopathic sudden sensorineural hearing loss: a retrospective case-control study. Jiang K, Li S, Cheng L, Yang J. Acta Otolaryngol; 2018 Nov; 138(11):998-1003. PubMed ID: 30465620 [Abstract] [Full Text] [Related]
47. Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss. Arslan N, Oğuz H, Demirci M, Şafak MA, İslam A, Kaytez SK, Samim E. Otol Neurotol; 2011 Apr; 32(3):393-7. PubMed ID: 21221047 [Abstract] [Full Text] [Related]
48. Intratympanic dexamethasone/hyaluronic acid mix as an adjunct to intravenous steroid and vasoactive treatment in patients with severe idiopathic sudden sensorineural hearing loss. Gouveris H, Schuler-Schmidt W, Mewes T, Mann W. Otol Neurotol; 2011 Jul; 32(5):756-60. PubMed ID: 21646933 [Abstract] [Full Text] [Related]
49. Sudden hearing loss: an effectivity comparison of intratympanic and systemic steroid treatments. Ermutlu G, Süslü N, Yılmaz T, Saraç S. Eur Arch Otorhinolaryngol; 2017 Oct; 274(10):3585-3591. PubMed ID: 28756569 [Abstract] [Full Text] [Related]
50. Efficacy of intratympanic corticosteroid, intravenous batroxobin and combined treatment for sudden sensorineural hearing loss with type-2 diabetes. Jia H, Yu Z, Li X, Wang J, Ge X, Chen ZT, Huang X, Wei Y. Acta Otolaryngol; 2019 Jun; 139(6):522-528. PubMed ID: 31008670 [Abstract] [Full Text] [Related]
51. Outcomes research analysis of continuous intratympanic glucocorticoid delivery in patients with acute severe to profound hearing loss: basis for planning randomized controlled trials. Plontke S, Löwenheim H, Preyer S, Leins P, Dietz K, Koitschev A, Zimmermann R, Zenner HP. Acta Otolaryngol; 2005 Aug; 125(8):830-9. PubMed ID: 16158529 [Abstract] [Full Text] [Related]
52. Intratympanic methylprednisolone perfusion as a salvage treatment for profound idiopathic sudden sensorineural hearing loss. Dai Y, Lu L, Hou J, Yang X, Li H, Yang Y, She W. J Laryngol Otol; 2017 May; 131(5):404-410. PubMed ID: 28290919 [Abstract] [Full Text] [Related]
53. Recovery of Idiopathic Sudden Sensorineural Hearing Loss. Edizer DT, Çelebi Ö, Hamit B, Baki A, Yiğit Ö. J Int Adv Otol; 2015 Aug; 11(2):122-6. PubMed ID: 26381001 [Abstract] [Full Text] [Related]
54. Intratympanic steroid injection versus hyperbaric oxygen therapy in refractory sudden sensorineural hearing loss: a meta-analysis. Kuo TC, Chao WC, Yang CH, Tsai MS, Tsai YT, Lee YC. Eur Arch Otorhinolaryngol; 2022 Jan; 279(1):83-90. PubMed ID: 33751195 [Abstract] [Full Text] [Related]
55. Comparison of Therapeutic Results with/without Additional Hyperbaric Oxygen Therapy in Idiopathic Sudden Sensorineural Hearing Loss: A Randomized Prospective Study. Tong B, Niu K, Ku W, Xie W, Dai Q, Hellström S, Duan M. Audiol Neurootol; 2021 Jan; 26(1):11-16. PubMed ID: 32535600 [Abstract] [Full Text] [Related]
56. Efficacy of low-dose intratympanic dexamethasone for sudden hearing loss. Günel C, Başal Y, Toka A, Eryılmaz A, Kurt Ömürlü I. Auris Nasus Larynx; 2015 Aug; 42(4):284-7. PubMed ID: 25725564 [Abstract] [Full Text] [Related]
57. Intratympanic corticosteroid injection as a first-line treatment of the patients with idiopathic sudden sensorineural hearing loss compared to systemic steroid: A systematic review and meta-analysis. Mirsalehi M, Ghajarzadeh M, Farhadi M, Akbarnejad Z, Ahmadi S, Salem MM. Am J Otolaryngol; 2022 Aug; 43(5):103505. PubMed ID: 35714500 [Abstract] [Full Text] [Related]
58. Pentoxifylline versus Steroid Therapy for Idiopathic Sudden Sensorineural Hearing Loss with Diabetes. Lan WC, Wang CY, Lin CD. J Int Adv Otol; 2018 Aug; 14(2):176-180. PubMed ID: 30100538 [Abstract] [Full Text] [Related]
59. Intratympanic steroids for combined treatment of idiopathic sudden hearing loss: when is it too late? Amarillo E, Navarro A, Hernández-García E, Plaza G. Acta Otolaryngol; 2019 Jul; 139(7):632-635. PubMed ID: 31124732 [Abstract] [Full Text] [Related]
60. The Short- and Long-Term Outcome of Intratympanic Steroid Therapy as a Salvage Treatment for Acute Low-Tone Sensorineural Hearing Loss without Episodes of Vertigo. Morita S, Nakamaru Y, Fujiwara K, Iizuka K, Masuya M, Homma A, Fukuda A, Fukuda S. Audiol Neurootol; 2016 Jul; 21(3):132-40. PubMed ID: 27077389 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]